|
ZKSCAN4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.74489999999317E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.40599999975954E-07 |
| Normal-vs-Stage2 |
1.306830E-01 |
| Normal-vs-Stage3 |
9.016400E-02 |
| Normal-vs-Stage4 |
2.940800E-01 |
| Stage1-vs-Stage2 |
7.347500E-02 |
| Stage1-vs-Stage3 |
6.156800E-03 |
| Stage1-vs-Stage4 |
4.315800E-03 |
| Stage2-vs-Stage3 |
8.184200E-01 |
| Stage2-vs-Stage4 |
5.681800E-01 |
| Stage3-vs-Stage4 |
6.673800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.6655000000001E-05 |
| Normal-vs-AfricanAmerican |
1.012440E-01 |
| Normal-vs-Asian |
1.757660E-02 |
| Caucasian-vs-AfricanAmerican |
6.987200E-01 |
| Caucasian-vs-Asian |
2.920300E-02 |
| AfricanAmerican-vs-Asian |
5.529900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.841460E-04 |
| Normal-vs-Female |
5.841100E-04 |
| Male-vs-Female |
9.728000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.760300E-02 |
| Normal-vs-Age(41-60Yrs) |
6.08360000042829E-07 |
| Normal-vs-Age(61-80Yrs) |
1.869510E-02 |
| Normal-vs-Age(81-100Yrs) |
9.050800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.502800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.296000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.154500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.243900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.608300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.387600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.202400E-03 |
| Normal-vs-Grade 2 |
5.74209999992803E-07 |
| Normal-vs-Grade 3 |
8.077200E-03 |
| Normal-vs-Grade 4 |
6.482800E-01 |
| Grade 1-vs-Grade 2 |
1.035250E-01 |
| Grade 1-vs-Grade 3 |
3.637500E-03 |
| Grade 1-vs-Grade 4 |
2.300500E-03 |
| Grade 2-vs-Grade 3 |
8.983300E-03 |
| Grade 2-vs-Grade 4 |
2.060700E-03 |
| Grade 3-vs-Grade 4 |
1.289050E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.4896000000153E-06 |
| Normal-vs-ccB subtype |
2.864700E-03 |
| ccA subtype-vs-ccB subtype |
1.344980E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.031600E-04 |
| Normal-vs-N1 |
2.708800E-01 |
| N0-vs-N1 |
9.680600E-01 |
|
|
